Financial News
Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
5.304
-0.506
(-8.70%)
Streaming Delayed Price
Updated: 1:45 PM EDT, Mar 31, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 11,993,704 |
| Open | 5.495 |
| Bid (Size) | 5.300 (54) |
| Ask (Size) | 5.310 (121) |
| Prev. Close | 5.810 |
| Today's Range | 5.190 - 5.510 |
| 52wk Range | 5.600 - 12.36 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why Recursion Pharmaceuticals Stock Is Sinking Today
March 10, 2025
Earnings Scheduled For February 28, 2025
February 28, 2025
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
February 21, 2025
25 Top AI Stocks That Could Boost Your Portfolio
February 18, 2025
Altitude Lab Startups Raise $154M in Capital
February 18, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.304
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 03/31/25 01:45 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
